Sign in to view content

Long Term Results of Pro Re Nata Regimen of Aflibercept Treatment in Recurrent or Persistent Neovascular Age-Releated Macular Degeneration

ILKAY KILIC MUFTUOGLU, MD

Video
Published 2016

Related

Use of Anti – VEGF Therapy for ROP: When and How
Updates from the Field
2017
Prospective Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: One-Year Outcomes
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2022
Interim Results From the SPECTRA Phase 2a Clinical Trial Evaluating Intravitreal 4D-150 in Adults WithDiabetic Macular Edema
David RP Almeida, MD, MBA, PhD, DABO, FRCSC, FASRS
Annual Meeting Talks
2025

Category: AMD-Neovascular

See more